A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks

NCT00884104 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

307

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Solifenacin

Sponsor

KYU-SUNG LEE

Collaborators

[object Object]